Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Ajanta Pharma Ltd.
Swot
Ajanta Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Ajanta Pharma Ltd. has 13 Strengths, 5 Weaknesses, 4 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(13)
Weakness
(5)
Opportunity
(4)
Threats
(2)
Others
(3)
Consistent Highest Return Stocks over Five Years - Nifty500
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Dividend yield greater than sector dividend yield
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Company with Low Debt
Top Gainers
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining Net Cash Flow : Companies not able to generate net cash
Increasing Trend in Non-Core Income
High promoter stock pledges
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
FII / FPI or Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months
Companies with high market cap, lower public shareholding
MFs decreased their shareholding last quarter
High Piotroski Score - Companies with strong financials
Expensive Performers (DVM)
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
